Contractor profile
AURAVAX THERAPEUTICS, INC.
Active registrationSelf Certified Small Disadvantaged BusinessSmall Business
UEIPAN3ZK2YLAL2
CAGE code969E2
Primary NAICS541714
LocationHOUSTON, TX, 77009
Federal obligations$749,999
Prime awards1
Active awards1
Latest award actionDec 19, 2025
Federal award activity
Public award recordTop federal customers
- Department of Health and Human Services1 awards$749,999
NAICS award mix
- 5417141 awards$749,999
PSC award mix
- AN141 awards$749,999
Contract vehicles
No supported records are available yet.
Potential recompetes
- Department of Health and Human Services$749,999
Prime award history
| Award | Agency / office | Category | Value | Dates |
|---|---|---|---|---|
| 75A50124C00054THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ASSESS THE ABILITY OF AURAVAX THERAPEUTICS? (AURAVAX) NOVEL MUCOSAL ADJUVANT NANOSTING-002, TOGETHER WITH INFLUENZA LIVE ATTENUATED VIRUS (LAV) CREATED WITH CODAGENIX NOVEL SYNTHETIC ATTENUATED VIRUS ENGIN | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | NAICS 541714PSC AN14 | $749,999 | Sep 23, 2024 – Dec 31, 2026 |
Award links and obligation totals come from USAspending.gov public records.
Industries and classifications
Public points of contact
JOSEPH SULLIIVANCEOGovernment business
JOSEPH SULLIIVANCEOElectronic business
EDEN COOPERPRESIDENTAlternate electronic business
Names and titles are reproduced from the public registration. FedRoster does not guess or enrich personal contact details.